In-vitro-derived human neutrophil precursor cells
US5955357A · kind A · utility
9Cited by
9References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 23, 1994 |
| Grant date | Sep 21, 1999 |
| Priority date | — |
| Expiry date | Aug 23, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/39
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a composition of human neutrophil precursor cells having at least 37% myeloblasts and promyeloblasts. Also provided are hematopoietic cell suspensions that have human neutrophil precursor cells and at least one hematopoietic growth factor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.